GMAB-DC

GMAB-DC

GMAB-DC

Letters With This Ticker

Quarter Letter Date Fund Name QTD YTD Tickers Keywords/Themes Theme Commentary Pitches Letter
2024 Q3 Sep 30, 2024 Orbis International Equity - - ABBV, GMAB DC, JNJ, NVO, REGN, ROG SW -
2025 Q1 Mar 31, 2025 Orbis Global Equity - - 402340 KS, ELV, GMAB DC, NVDA -
2025 Q3 Oct 20, 2025 Baillie Gifford – International Alpha 6.7% 19.5% 0XXT LN, BHP AU, COIN, EDEN FP, ENSG, ENTG, GMAB DC, MEDP, MSCI, NVO, SHOP, UNH Artificial Intelligence, Digital Platforms, Global Growth, Healthcare Innovation, semiconductors

Pitches With This Ticker

Date Pitch Type Author Company Industry Sub Industry Bull / Bear Stock Exchange Keywords Action
Nov 29, 2025 Fund Letters Ben Preston Genmab A/S Health Care Biotechnology Bull NASDAQ Adcs, Antibody platform, Keytruda-like royalties, Patent cliff, pipeline, rerating, royalties

BSD Shareholders of GMAB-DC

This report provides a detailed summary of investor holdings for a specified stock ticker, highlighting key metrics such as fund name, total assets under management (AUM), invested value, portfolio weight, and shares owned. It also tracks changes in share ownership during the last quarter, including the percentage of shares bought or sold and the percentage of outstanding shares owned. The data is generated using an API that processes investor holdings and calculates these values for each fund. This report helps investors and analysts monitor the stock positions of major funds, identify investment trends, and assess the influence of large investors on individual stocks.

Filing Date: September 30, 2025
Manager Name Fund Name Fund AUM Invested Value Portfolio Weight Shares Owned Shares Bought / Sold During Quarter % Bought / Sold During Quarter % of Shares Outstanding Owned
No investor data available.